ASX - By Stock
|
NEU |
Re:
Share Price
|
|
mw03
|
9.9K |
4.4M |
4 |
17/09/23 |
17/09/23 |
ASX - By Stock
|
9.9K
|
4.4M
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Neuren commences Phase 2 trial of NNZ-2591 in Angelman
|
|
mw03
|
30 |
15K |
33 |
10/07/23 |
10/07/23 |
ASX - By Stock
|
30
|
15K
|
33
|
|
ASX - By Stock
|
NEU |
Re:
Trial participants video
|
|
mw03
|
5 |
2.4K |
12 |
23/05/23 |
23/05/23 |
ASX - By Stock
|
5
|
2.4K
|
12
|
|
ASX - By Stock
|
NEU |
Re:
Trial participants video
|
|
mw03
|
5 |
2.4K |
14 |
23/05/23 |
23/05/23 |
ASX - By Stock
|
5
|
2.4K
|
14
|
|
ASX - By Stock
|
NEU |
Re:
Wilsons target $18.29 and summary
|
|
mw03
|
65 |
35K |
87 |
20/04/23 |
20/04/23 |
ASX - By Stock
|
65
|
35K
|
87
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
mw03
|
946 |
470K |
7 |
05/04/23 |
05/04/23 |
ASX - By Stock
|
946
|
470K
|
7
|
|
ASX - By Stock
|
NEU |
Re:
Media News
|
|
mw03
|
221 |
95K |
16 |
25/03/23 |
25/03/23 |
ASX - By Stock
|
221
|
95K
|
16
|
|
ASX - By Stock
|
NEU |
Re:
Media News
|
|
mw03
|
221 |
95K |
16 |
25/03/23 |
25/03/23 |
ASX - By Stock
|
221
|
95K
|
16
|
|
ASX - By Stock
|
NEU |
Re:
Media News
|
|
mw03
|
221 |
95K |
14 |
23/03/23 |
23/03/23 |
ASX - By Stock
|
221
|
95K
|
14
|
|
ASX - By Stock
|
NEU |
Re:
NEU
|
|
mw03
|
12 |
8.8K |
35 |
21/03/23 |
21/03/23 |
ASX - By Stock
|
12
|
8.8K
|
35
|
|
Charts
|
NEU |
Re:
ASX 200 - March rebalance
|
|
mw03
|
54 |
28K |
6 |
19/03/23 |
19/03/23 |
Charts
|
54
|
28K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Investor Presentation, 14 March 2023
|
|
mw03
|
145 |
69K |
14 |
14/03/23 |
14/03/23 |
ASX - By Stock
|
145
|
69K
|
14
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
mw03
|
9.9K |
4.4M |
13 |
12/03/23 |
12/03/23 |
ASX - By Stock
|
9.9K
|
4.4M
|
13
|
|
ASX - By Stock
|
NEU |
Re:
Survey of predictions
|
|
mw03
|
20 |
9.4K |
0 |
12/03/23 |
12/03/23 |
ASX - By Stock
|
20
|
9.4K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
mw03
|
9.9K |
4.4M |
12 |
03/01/23 |
03/01/23 |
ASX - By Stock
|
9.9K
|
4.4M
|
12
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
mw03
|
9.9K |
4.4M |
21 |
25/12/22 |
25/12/22 |
ASX - By Stock
|
9.9K
|
4.4M
|
21
|
|
ASX - By Stock
|
KZA |
Re:
Ann: AGM materials
|
|
mw03
|
30 |
10K |
4 |
17/11/22 |
17/11/22 |
ASX - By Stock
|
30
|
10K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Q3 2022 quarterly activity and cash flow report
|
|
mw03
|
5 |
4.0K |
9 |
02/11/22 |
02/11/22 |
ASX - By Stock
|
5
|
4.0K
|
9
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
mw03
|
9.9K |
4.4M |
25 |
17/10/22 |
17/10/22 |
ASX - By Stock
|
9.9K
|
4.4M
|
25
|
|
ASX - By Stock
|
NEU |
Re:
Science & medicine
|
|
mw03
|
15 |
10K |
27 |
05/09/22 |
05/09/22 |
ASX - By Stock
|
15
|
10K
|
27
|
|
ASX - By Stock
|
NEU |
Re:
Science & medicine
|
|
mw03
|
15 |
10K |
50 |
02/09/22 |
02/09/22 |
ASX - By Stock
|
15
|
10K
|
50
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Acadia submits Rett Syndrome New Drug Application to the FDA
|
|
mw03
|
95 |
47K |
61 |
19/07/22 |
19/07/22 |
ASX - By Stock
|
95
|
47K
|
61
|
|
ASX - By Stock
|
NEU |
Re:
Market Capitalisation is a Better Valuation Metric Than Share Price
|
|
mw03
|
100 |
62K |
1 |
02/06/22 |
02/06/22 |
ASX - By Stock
|
100
|
62K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Market Capitalisation is a Better Valuation Metric Than Share Price
|
|
mw03
|
100 |
62K |
14 |
02/06/22 |
02/06/22 |
ASX - By Stock
|
100
|
62K
|
14
|
|
Humour
|
|
Royal Jelly
|
|
mw03
|
1 |
721 |
0 |
17/05/22 |
17/05/22 |
Humour
|
1
|
721
|
0
|
|
ASX - By Stock
|
NEU |
Re:
A De-risked bio-tech with 4X upside - Karst Peak Capital
|
|
mw03
|
73 |
44K |
33 |
20/03/22 |
20/03/22 |
ASX - By Stock
|
73
|
44K
|
33
|
|
ASX - By Stock
|
NEU |
Re:
What is NNZ-2591 really worth?
|
|
mw03
|
21 |
17K |
41 |
06/03/22 |
06/03/22 |
ASX - By Stock
|
21
|
17K
|
41
|
|
ASX - By Stock
|
NEU |
Re:
Ann: 2021 Results - a transformational year for Neuren
|
|
mw03
|
75 |
34K |
23 |
27/02/22 |
27/02/22 |
ASX - By Stock
|
75
|
34K
|
23
|
|
Humour
|
|
Re:
: It's A Win :-: Win :--->
|
|
mw03
|
3 |
1.3K |
3 |
14/02/22 |
14/02/22 |
Humour
|
3
|
1.3K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
mw03
|
77 |
19K |
8 |
02/02/22 |
02/02/22 |
ASX - By Stock
|
77
|
19K
|
8
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Q4 2021 quarterly activity and cash flow report
|
|
mw03
|
42 |
17K |
14 |
31/01/22 |
31/01/22 |
ASX - By Stock
|
42
|
17K
|
14
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Q4 2021 quarterly activity and cash flow report
|
|
mw03
|
42 |
17K |
34 |
31/01/22 |
31/01/22 |
ASX - By Stock
|
42
|
17K
|
34
|
|
ASX - By Stock
|
MP1 |
Re:
Explain megaport like I'm 5
|
|
mw03
|
23 |
26K |
8 |
02/01/22 |
02/01/22 |
ASX - By Stock
|
23
|
26K
|
8
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Positive topline results from Phase 3 trial in Rett syndrome
|
|
mw03
|
52 |
29K |
42 |
26/12/21 |
26/12/21 |
ASX - By Stock
|
52
|
29K
|
42
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Neuren receives feedback on IND for Phelan-McDermid syndrome
|
|
mw03
|
21 |
11K |
9 |
25/10/21 |
25/10/21 |
ASX - By Stock
|
21
|
11K
|
9
|
|
ASX - By Stock
|
NEU |
Re:
Ann: US patent to 2034 granted for Neuren's NNZ-2591 in autism
|
|
mw03
|
34 |
19K |
14 |
19/10/21 |
19/10/21 |
ASX - By Stock
|
34
|
19K
|
14
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Notification of investor webinar
|
|
mw03
|
14 |
6.3K |
43 |
19/08/21 |
19/08/21 |
ASX - By Stock
|
14
|
6.3K
|
43
|
|
Humour
|
|
Re:
A woman's wild words
|
|
mw03
|
45 |
12K |
2 |
19/06/21 |
19/06/21 |
Humour
|
45
|
12K
|
2
|
|
General
|
|
Re:
Harry
|
|
mw03
|
2 |
499 |
5 |
15/05/21 |
15/05/21 |
General
|
2
|
499
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Initiates FTO Directed Kidney Cancer Preclinical Study
|
|
mw03
|
95 |
27K |
12 |
25/03/21 |
25/03/21 |
ASX - By Stock
|
95
|
27K
|
12
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Initiates FTO Directed Kidney Cancer Preclinical Study
|
|
mw03
|
95 |
27K |
26 |
25/03/21 |
25/03/21 |
ASX - By Stock
|
95
|
27K
|
26
|
|
ASX - By Stock
|
ZNO |
Re:
Zoono working 24/7 to fill orders
|
|
mw03
|
432 |
143K |
3 |
30/03/20 |
30/03/20 |
ASX - By Stock
|
432
|
143K
|
3
|
|
ASX - By Stock
|
ZNO |
Re:
French defeat coronavirus Vive la France !!
|
|
mw03
|
35 |
11K |
10 |
24/03/20 |
24/03/20 |
ASX - By Stock
|
35
|
11K
|
10
|
|
ASX - By Stock
|
ZNO |
Re:
100 coronavirus patients recover in NY hospital
|
|
mw03
|
40 |
12K |
4 |
22/03/20 |
22/03/20 |
ASX - By Stock
|
40
|
12K
|
4
|
|
ASX - By Stock
|
ZNO |
Re:
Chart
|
|
mw03
|
7.5K |
12M |
4 |
16/03/20 |
16/03/20 |
ASX - By Stock
|
7.5K
|
12M
|
4
|
|
ASX - By Stock
|
ZNO |
Re:
Chart
|
|
mw03
|
7.5K |
12M |
5 |
02/03/20 |
02/03/20 |
ASX - By Stock
|
7.5K
|
12M
|
5
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia presents at Biotech Showcase
|
|
mw03
|
55 |
18K |
9 |
14/01/20 |
14/01/20 |
ASX - By Stock
|
55
|
18K
|
9
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Becoming a substantial holder
|
|
mw03
|
2 |
6.4K |
0 |
12/09/19 |
12/09/19 |
ASX - By Stock
|
2
|
6.4K
|
0
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Becoming a substantial holder
|
|
mw03
|
2 |
6.4K |
1 |
11/09/19 |
11/09/19 |
ASX - By Stock
|
2
|
6.4K
|
1
|
|
ASX - By Stock
|
APX |
Re:
RBC - New Target now $34
|
|
mw03
|
198 |
215K |
3 |
28/08/19 |
28/08/19 |
ASX - By Stock
|
198
|
215K
|
3
|
|